Related references
Note: Only part of the references are listed.Interaction of hydroxylated collagen IV with the von Hippel-Lindau tumor suppressor
Alexandra Grosfeld et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Identification of novel VHL targets that are associated with the development of renal cell carcinoma
M. Abdulrahman et al.
ONCOGENE (2007)
The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma
William G. Kaelin
CLINICAL CANCER RESEARCH (2007)
Primary cilium formation requires von Hippel-Lindau gene function in renal-derived cells
Mallory S. Lutz et al.
CANCER RESEARCH (2006)
Formation of primary cilia in the renal epithelium is regulated by the von Hippel-Lindau tumor suppressor protein
Miguel A. Esteban et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
p53 stabilization and transactivation by a von Hippel-Lindau protein
Jae-Seok Roe et al.
MOLECULAR CELL (2006)
Regulation of E-cadherin expression by VHL and hypoxia-inducible factor
MA Esteban et al.
CANCER RESEARCH (2006)
Tumor suppressor candidate TSSC5 is regulated by UbcH6 and a novel ubiquitin ligase RING105
HY Yamada et al.
ONCOGENE (2006)
Integrins regulate VE-cadherin and catenins: Dependence of this regulation on Src,, but not on Ras
YX Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
von Hippel-Lindau tumor suppressor protein regulates the assembly of intercellular junctions in renal cancer cells through hypoxia-inducible factor-independent mechanisms
MJ Calzada et al.
CANCER RESEARCH (2006)
PVHL modification by NEDD8 is required for fibronectin matrix assembly and suppression of tumor development
NH Stickle et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Cell adhesion and signalling by cadherins and Ig-CAMs in cancer
U Cavallaro et al.
NATURE REVIEWS CANCER (2004)
Fibronectin is a hypoxia-independent target of the tumor suppressor VHL
HAR Bluyssen et al.
FEBS LETTERS (2004)
Integrin signalling during tumour progression
WJ Guo et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Role of VHL gene mutation in human cancer
WY Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray data
ME Lenburg et al.
BMC CANCER (2003)
Inhibition of HIF2 alpha is sufficient to suppress pVHL-defective tumor growth
K Kondo et al.
PLOS BIOLOGY (2003)
Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL
A Hergovich et al.
NATURE CELL BIOLOGY (2003)
Integrins: Bidirectional, allosteric signaling machines
RO Hynes
CELL (2002)
HIF-1α binding to VHL is regulated by stimulus-sensitive proline hydroxylation
F Yu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF
MA Hoffman et al.
HUMAN MOLECULAR GENETICS (2001)
VHL induces renal cell differentiation and growth arrest through integration of cell-cell and cell-extracellular matrix signaling
EJ Davidowitz et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Integrin α3β1 engagement disrupts intercellular adhesion
K Kawano et al.
EXPERIMENTAL CELL RESEARCH (2001)
Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling
CC Wykoff et al.
ONCOGENE (2000)
Elongin BC complex prevents degradation of von Hippel-Lindau tumor suppressor gene products
AR Schoenfeld et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
